NSE · EMCURE
Emcure Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#243
of 5,096 stocks
▲ 11W
Peak #242 · 27 Sep 2026
A largecap name in Healthcare, Emcure Pharmaceuticals Limited remains firmly promoter-controlled, with promoters holding 78%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
36,566.90 Cr
P/E Ratio
39.53
P/B Ratio
7.34
ROE
18.91%
ROCE
25.65%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 2,580.45 Cr | 2,469.70 Cr | 2,363.48 Cr | 2,269.82 Cr |
| Net Profit | 292.49 Cr | 243.74 Cr | 231.37 Cr | 251.37 Cr |
| EPS | 15.50 | 12.84 | 12.16 | 12.85 |
| Operating Profit | 425.06 Cr | 377.28 Cr | 389.92 Cr | 373.96 Cr |
Shareholding pattern
Promoter
77.83%
Public
22.17%
PUBLIC BREAKDOWN
FII
4.88%
DII
8.46%
MF (within DII)
6.87%
Individuals
7.20%
Mutual fund holdings
₹2,449.96
Cr total
64
Schemes
19
Fund Houses
₹2,449.96 Cr
Total Exposure
Kotak Mahindra Mutual Fund₹812.87 Cr (33.2%)
Aditya Birla Sun Life Mutual Fund₹508.44 Cr (20.8%)
Nippon India Mutual Fund₹432.52 Cr (17.7%)
SBI Mutual Fund₹214.91 Cr (8.8%)
Axis Mutual Fund₹168.20 Cr (6.9%)
Others₹313.02 Cr (12.8%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 14 Aug 2025 | Dividend | Dividend - Rs 3 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.